RxDoctor Payments Data

Lisa Keller, PA

Physician Assistant · Littleton, CONPI 1205051562

Payments from drug & device makers

$7,673in general payments, 2019–2025

Across 396 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$648
  • Pfizer$583
  • Novo Nordisk$456
  • Boehringer Ingelheim$416
  • Johnson & Johnson$411
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$7,54698%
  • Education$1262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,673 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$29,486
Medicare patients
137
Services billed
488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$55,914
JardianceEmpagliflozin34$36,716
EliquisApixaban23$31,189
UbrelvyUbrogepant13$25,413
MounjaroTirzepatide22$24,969
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$24,087
SavellaMilnacipran Hcl12$9,085
NamzaricMemantine Hcl/Donepezil Hcl12$7,199
ArexvyRsvpref3 Antigen/As01e/Pf17$5,165
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$5,118
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$3,402
ShingrixVaricella-Zoster Ge/As01b/Pf15$3,254
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf37$2,594
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,445
Icosapent Ethyl11$2,235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$456$55,91443 claims
AbbVieUbrelvy, Savella, Namzaric, Synthroid$1,551$43,42757 claims
Boehringer IngelheimJardiance$416$36,71634 claims
GSKTrelegy Ellipta, Arexvy, Shingrix$312$32,50664 claims
PfizerEliquis$583$31,18923 claims
Lilly USA, LLCMounjaro$295$24,96922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →